Is It Policy And Not Treatment That Actually Determines Epilepsy Outcomes?

Epilepsy is among the most prevalent and treatable neurological disorders worldwide, yet it remains associated with persistent and preventable inequities in morbidity and mortality. Despite major advances in diagnostics, pharmacotherapy, and surgery, substantial treatment gaps and excess mortality persist globally across all income segments of society. These outcomes frequently reflect failures of access, continuity, and health-system design, rather than limitations of existing therapies. Using epilepsy specifically as a tracer neurological condition, this analysis examines how health systems respond to chronic neurological disease under stress. In many low- and middle-income countries and other underserved settings, health systems have evolved passively, shaped by fragmented financing, short-term priorities, and misaligned incentives rather than by intentional, outcome-oriented policy. Evidence from global neurology and health economics shows that such passive system development produces reactive care models, inefficient resource use, and high indirect costs due to productivity loss, caregiver burden, injury, disability, and premature mortality. Environmental and climate-related stressors further expose these structural weaknesses in vulnerable regions. Extreme weather events, environmental instability, and displacement disrupt medication supply, infrastructure, and continuity of neurological care. In epilepsy, even brief interruptions in treatment can precipitate breakthrough seizures, injury, or death, transforming environmental exposure into avoidable neurological harm. This article contends that policy is the primary determinant of whether health systems remain reactive or become resilient. Secondly, we propose that artificial intelligence (AI) may play a critical enabling role by supporting the development of context-appropriate policy and system design. When aligned with local realities, AI-facilitated policy could enable earlier diagnosis, sustained treatment, and more efficient resource allocation. Proactive epilepsy care is therefore not only an ethical imperative but an economically rational strategy. Aligning policy, technology, and health system design is essential to deliver durable, equitable, and cost-effective epilepsy care in an era of accelerating environmental and geopolitical change where external funding is diminishing globally.